✦ LIBER ✦

Pemetrexed: A promising new treatment for breast cancer

✍ Scribed by Joyce A. O'Shaughnessy; Alessandra Gennari; PierFranco Conte

Book ID: 114106570
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 81 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(02)70214-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed (Alimta): A promising new age

Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer

✍ Hilary Calvert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Pemetrexed: An active new agent for brea

Pemetrexed: An active new agent for breast cancer

✍ Joyce A. O'Shaughnessy 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Promising switch to anastrozole for brea

Promising switch to anastrozole for breast-cancer treatment

✍ Vivien Chen 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 59 KB

RANKL inhibition: a promising novel stra

RANKL inhibition: a promising novel strategy for breast cancer treatment

✍ Eva González-Suárez 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 355 KB

A promising drug for breast cancer

✍ Lynn Payer 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 66 KB

Review of a promising new agent—pemetrex

Review of a promising new agent—pemetrexed disodium

✍ Luis Paz-Ares; Susana Bezares; José M. Tabernero; Daniel Castellanos; Hernán Cor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Pemetrexed disodium (ALIMTa, [pemetrexed], LY231514; Eli Lilly and Company; Indianapolis, IN), a novel antifolate antimetabolite with multiple enzyme targets involved in both pyrimidine and purine synthesis, has entered clinical trials due to its favorable pleclinical profile. Many studies utilizing